50 | ruxolitinibIBA
06/2023
-
09/2009 |
28 | Janus Kinase InhibitorsIBA
06/2023
-
01/2013 |
14 | N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
02/2024
-
04/2012 |
12 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
10/2023
-
04/2012 |
12 | fedratinibIBA
01/2022
-
09/2009 |
11 | Janus KinasesIBA
11/2023
-
03/2012 |
10 | Syntex adjuvant formulationIBA
02/2024
-
07/2011 |
9 | Hemoglobins (Hemoglobin)IBA
04/2021
-
04/2003 |
8 | Thalidomide (Thalomid)FDA Link
01/2011
-
05/2002 |
6 | Hydroxyurea (Hydrea)FDA LinkGeneric
12/2022
-
05/2008 |
6 | Janus Kinase 2IBA
05/2021
-
03/2008 |
6 | Proteins (Proteins, Gene)FDA Link
01/2021
-
08/2008 |
6 | Janus Kinase 1IBA
12/2017
-
12/2013 |
6 | CytokinesIBA
07/2015
-
05/2002 |
5 | Phosphotransferases (Kinase)IBA
01/2020
-
07/2005 |
5 | Lenalidomide (CC 5013)FDA Link
04/2012
-
08/2006 |
5 | Prednisone (Sone)FDA LinkGeneric
01/2011
-
04/2003 |
4 | InterferonsIBA
12/2022
-
05/2011 |
4 | pomalidomideIBA
01/2015
-
09/2009 |
4 | Imatinib Mesylate (Gleevec)FDA Link
03/2013
-
05/2002 |
4 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2007
-
04/2005 |
3 | CollagenIBA
01/2021
-
07/2004 |
3 | Immunomodulating AgentsIBA
07/2017
-
01/2010 |
3 | ErythropoietinFDA Link
01/2013
-
08/2002 |
3 | Cytarabine (Cytosar-U)FDA LinkGeneric
03/2012
-
07/2005 |
3 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2008
-
03/2002 |
2 | activin AIBA
11/2023
-
10/2023 |
2 | Danazol (Azol)FDA LinkGeneric
11/2023
-
04/2021 |
2 | LigandsIBA
12/2022
-
08/2008 |
2 | Telomerase (Telomerase Reverse Transcriptase)IBA
12/2022
-
01/2016 |
2 | IronIBA
04/2021
-
01/2015 |
2 | DecitabineFDA Link
10/2020
-
12/2018 |
2 | CreatinineIBA
10/2017
-
08/2015 |
2 | Azacitidine (5 Azacytidine)FDA Link
10/2015
-
01/2015 |
2 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2014
-
06/2013 |
2 | adavosertibIBA
04/2014
-
03/2012 |
2 | Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2011
-
07/2005 |
2 | tanespimycin (17AAG)IBA
11/2011
-
07/2005 |
2 | Checkpoint Kinase 1IBA
11/2011
-
07/2005 |
2 | 17-aminogeldanamycinIBA
11/2011
-
07/2005 |
2 | DNA (Deoxyribonucleic Acid)IBA
03/2008
-
11/2006 |
2 | Etanercept (Enbrel)FDA Link
08/2002
-
03/2002 |
1 | TESIBA
12/2023 |
1 | Activin Receptors (Activin Receptor)IBA
10/2023 |
1 | HepcidinsIBA
10/2023 |
1 | luspaterceptIBA
12/2022 |
1 | PRM-151IBA
12/2022 |
1 | navitoclaxIBA
12/2022 |